Revelation Biosciences, Inc.

REVB ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
SC 13G/A Oct 12, 2021 SCHEDULE 13G/A
425 Oct 4, 2021 FORM 425
425 Sep 28, 2021 FORM 425
SC 13G Sep 28, 2021 SCHEDULE 13G
DEFR14A Sep 24, 2021 DEFINITIVE PROXY STATEMENT
8-K Sep 23, 2021 CURRENT REPORT
4 Sep 23, 2021 OWNERSHIP DOCUMENT
DEF 14A Sep 21, 2021 DEFINITIVE PROXY STATEMENT
S-4 Sep 20, 2021 REGISTRATION STATEMENT
PRE 14A Sep 7, 2021 PRELIMINARY PROXY STATEMENT
425 Sep 2, 2021 CURRENT REPORT
8-K Sep 2, 2021 CURRENT REPORT
DEFA14A Aug 31, 2021 CURRENT REPORT
8-K Aug 31, 2021 CURRENT REPORT
10-Q Aug 23, 2021 FORM 10-Q
NT 10-Q Aug 17, 2021 NOTIFICATION OF LATE FILING
SC 13G Aug 10, 2021 KARPUS INVESTMENT MGT / PETRA ACQUISITION - SCHEDULE 13G
10-Q Jun 22, 2021 QUARTERLY REPORT
10-K/A Jun 16, 2021 AMENDMENT NO. 1 TO FORM 10-K
8-K Jun 16, 2021 CURRENT REPORT
8-K Jun 1, 2021 CURRENT REPORT
NT 10-Q May 18, 2021 NOTIFICATION OF LATE FILING
10-K Mar 31, 2021 ANNUAL REPORT
3 Mar 11, 2021 PRIMARY DOCUMENT
8-K/A Mar 5, 2021 AMENDMENT TO FORM 8-K
← Newer Page 14 of 16 · 387 filings Older →